Generation of human induced pluripotent stem cells from dermal fibroblasts

doi:10.1073/pnas.0711983105

Generation of human induced pluripotent stem cells from dermal fibroblasts

Departments of *Molecular Cell and Developmental Biology,
^‖Biological Chemistry, and
**Microbiology, Immunology, and Molecular Genetics,
^†Molecular Biology Institute,
^‡Jonsson Comprehensive Cancer Center, and
^§Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, 615 Charles E. Young Drive South, University of California, Los Angeles, CA 90095

Communicated by Owen N. Witte, University of California, Los Angeles, CA, December 19, 2007 (received for review December 5, 2007)

Abstract

The generation of patient-specific pluripotent stem cells has the potential to accelerate the implementation of stem cells for clinical treatment of degenerative diseases. Technologies including somatic cell nuclear transfer and cell fusion might generate such cells but are hindered by issues that might prevent them from being used clinically. Here, we describe methods to use dermal fibroblasts easily obtained from an individual human to generate human induced pluripotent stem (iPS) cells by ectopic expression of the defined transcription factors KLF4, OCT4, SOX2, and C-MYC. The resultant cell lines are morphologically indistinguishable from human embryonic stem cells (HESC) generated from the inner cell mass of a human preimplantation embryo. Consistent with these observations, human iPS cells share a nearly identical gene-expression profile with two established HESC lines. Importantly, DNA fingerprinting indicates that the human iPS cells were derived from the donor material and are not a result of contamination. Karyotypic analyses demonstrate that reprogramming of human cells by defined factors does not induce, or require, chromosomal abnormalities. Finally, we provide evidence that human iPS cells can be induced to differentiate along lineages representative of the three embryonic germ layers indicating the pluripotency of these cells. Our findings are an important step toward manipulating somatic human cells to generate an unlimited supply of patient-specific pluripotent stem cells. In the future, the use of defined factors to change cell fate may be the key to routine nuclear reprogramming of human somatic cells.

Footnotes

^¶To whom correspondence may be addressed. E-mail: blowry{at}ucla.edu or kplath{at}mednet.ucla.edu
Author contributions: L.R. and R.Y. contributed equally to this work; W.E.L., A.D.P., A.T.C., and K.P. designed research; W.E.L., L.R., R.Y., A.D.P., J.T., R.S., and K.P. performed research; W.E.L., A.D.P., and K.P. contributed new reagents/analytic tools; W.E.L., J.T., R.S., A.T.C., and K.P. analyzed data; and W.E.L. and K.P. wrote the paper.
The authors declare no conflict of interest.
Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE9865).
This article contains supporting information online at www.pnas.org/cgi/content/full/0711983105/DC1.